© Insempra

Series A financing: Insempra receives 18.6 million euros

Munich-based biotech company Insempra has successfully raised €18.6 million in its Series A funding round. The financing was led by EQT Ventures, with additional investors including Bayern Kapital, Henkel dx Ventures, and Alante Capital.

Insempra develops bio-based and biodegradable synthetic ingredients, materials, and fibers. The startup aims to offer sustainable alternatives to materials currently produced primarily from agricultural or petrochemical sources, as their production often involves environmental pollution and the exploitation of natural resources. For example, Insempra's Biotreasure team uses a special yeast to produce materials such as polyesters and polyamides from plant residues, used cooking oil, or PET waste. This development is also supported by a Sprint promotion supported. Functional ingredients such as flavors or fragrances are already on the market with Insempra.

Now could the startup The startup has successfully closed its Series A funding round, raising €18.6 million ($20 million). The funding was led by existing investor EQT Ventures. Other investors include Bayern Kapital, Henkel dx Ventures, and Alante Capital. Existing investors BlueYard Capital, Possible Ventures, Taavet Sten, and Acequia Capital also participated in the round. The startup plans to use the new funds to further develop and launch its products.

Jens Klein, founder and CEO of Insempra, explains:

„We are grateful for the support of our investors, who immediately recognized the potential of our market-leading processes and innovative technology platform. Our goal is to further expand our capacities to develop sustainable, high-quality materials that help reduce the dependence of manufacturing companies on chemical industrial materials.“

EQT Ventures: Insempra will drive „a revolution in industrial manufacturing“.

Ted Persson, partner at EQT Ventures, adds:

„Insempra has both the team and the technology to drive a revolution in industrial manufacturing and achieve rapid market penetration for its products. New technology platforms like Insempra’s have the potential to dramatically transform the manufacturing processes of several multi-billion-dollar industries and develop customized ingredients to meet market needs.“

And Monika Steger, Managing Director of Bayern Kapital, says:

„Global awareness of how we extract and use resources has changed. Consumers and end customers are increasingly demanding sustainability and climate protection, policymakers are tightening regulatory frameworks, and companies must adapt as a result. In all sectors, from cosmetics, fashion, and personal care to food, manufacturers are therefore searching for sustainable alternatives for the base materials and ingredients in their products. Insempra can develop precisely such sustainable production methods. The scaling potential of this innovative technology is enormous. That's why we are happy to support Insempra in its growth.“

Read more ↓